Cargando…
Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential positio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269726/ https://www.ncbi.nlm.nih.gov/pubmed/37070985 http://dx.doi.org/10.1128/spectrum.04702-22 |
_version_ | 1785059235169566720 |
---|---|
author | Wang, Yuhang Su, Junfeng Zhou, Ziyan Yang, Jie Liu, Wenjuan Zhang, Yafen Zhang, Pengyu Guo, Tingting Li, Guocai |
author_facet | Wang, Yuhang Su, Junfeng Zhou, Ziyan Yang, Jie Liu, Wenjuan Zhang, Yafen Zhang, Pengyu Guo, Tingting Li, Guocai |
author_sort | Wang, Yuhang |
collection | PubMed |
description | As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential position in adjuvants of antibiotics. This study found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens. Mechanism studies have shown that baicalein causes membrane disruption by attaching to phospholipids on the Gram-negative bacterial cytoplasmic membrane and lipopolysaccharides on the outer membrane. This process facilitates the entry of doxycycline into bacteria. Through collaborative strategies, baicalein can also increase the production of reactive oxygen species and inhibit the activities of multidrug efflux pumps and biofilm formation to potentiate antibiotic efficacy. Additionally, baicalein attenuates the lipopolysaccharide-induced inflammatory response in vitro. Finally, baicalein can significantly improve doxycycline efficacy in mouse lung infection models. The present study showed that baicalein might be considered a lead compound, and it should be further optimized and developed as an adjuvant that helps combat antibiotic resistance. IMPORTANCE Doxycycline is an important broad-spectrum tetracycline antibiotic used for treating multiple human infections, but its resistance rates are recently rising globally. Thus, new agents capable of boosting the effectiveness of doxycycline need to be discovered. In this study, it was found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens in vitro and in vivo. Due to its low cytotoxicity and resistance, the combination of baicalein and doxycycline provides a valuable clinical reference for selecting more effective therapeutic strategies for treating infections caused by multidrug-resistant Gram-negative clinical isolates. |
format | Online Article Text |
id | pubmed-10269726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102697262023-06-16 Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline Wang, Yuhang Su, Junfeng Zhou, Ziyan Yang, Jie Liu, Wenjuan Zhang, Yafen Zhang, Pengyu Guo, Tingting Li, Guocai Microbiol Spectr Research Article As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential position in adjuvants of antibiotics. This study found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens. Mechanism studies have shown that baicalein causes membrane disruption by attaching to phospholipids on the Gram-negative bacterial cytoplasmic membrane and lipopolysaccharides on the outer membrane. This process facilitates the entry of doxycycline into bacteria. Through collaborative strategies, baicalein can also increase the production of reactive oxygen species and inhibit the activities of multidrug efflux pumps and biofilm formation to potentiate antibiotic efficacy. Additionally, baicalein attenuates the lipopolysaccharide-induced inflammatory response in vitro. Finally, baicalein can significantly improve doxycycline efficacy in mouse lung infection models. The present study showed that baicalein might be considered a lead compound, and it should be further optimized and developed as an adjuvant that helps combat antibiotic resistance. IMPORTANCE Doxycycline is an important broad-spectrum tetracycline antibiotic used for treating multiple human infections, but its resistance rates are recently rising globally. Thus, new agents capable of boosting the effectiveness of doxycycline need to be discovered. In this study, it was found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens in vitro and in vivo. Due to its low cytotoxicity and resistance, the combination of baicalein and doxycycline provides a valuable clinical reference for selecting more effective therapeutic strategies for treating infections caused by multidrug-resistant Gram-negative clinical isolates. American Society for Microbiology 2023-04-18 /pmc/articles/PMC10269726/ /pubmed/37070985 http://dx.doi.org/10.1128/spectrum.04702-22 Text en Copyright © 2023 Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Wang, Yuhang Su, Junfeng Zhou, Ziyan Yang, Jie Liu, Wenjuan Zhang, Yafen Zhang, Pengyu Guo, Tingting Li, Guocai Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title | Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title_full | Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title_fullStr | Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title_full_unstemmed | Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title_short | Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline |
title_sort | baicalein resensitizes multidrug-resistant gram-negative pathogens to doxycycline |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269726/ https://www.ncbi.nlm.nih.gov/pubmed/37070985 http://dx.doi.org/10.1128/spectrum.04702-22 |
work_keys_str_mv | AT wangyuhang baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT sujunfeng baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT zhouziyan baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT yangjie baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT liuwenjuan baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT zhangyafen baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT zhangpengyu baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT guotingting baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline AT liguocai baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline |